A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR Trial and ESPOIR Registry data\u2020

OBJECTIVES: Decellularized pulmonary homografts (DPH) have shown excellent results for pulmonary valve replacement. However, controlled multicentre studies are lacking to date.METHODS: Prospective European multicentre trial evaluating DPH for pulmonary valve replacement. Matched comparison of DPH to bovine jugular vein (BJV) conduits and cryopreserved homografts (CH) considering patient age, type of heart defect and previous procedures.RESULTS: In total, 121 patients (59 female) were prospectively enrolled (August 2014-December 2016), age 21.3 +/- 14.4 years, DPH diameter 24.4 +/- 2.8 mm. No adverse events occurred with respect to surgical handling; there were 2 early deaths (30 + 59 years) due to myocardial failure after multi-valve procedures and no late mortality (1.7% mortality). After a mean follow-up of 2.2 +/- 0.6 years, the primary efficacy end points mean peak gradient (16.1 +/- 12.1 mmHg) and regurgitation (mean 0.25 +/- 0.48, grade 0-3) were excellent. One reoperation was required for recurrent subvalvular stenosis caused by a pericardial patch and 1 balloon dilatation was performed on a previously stented LPA. 100% follow-up for DPH patients operated before or outside the trial (n = 114) included in the ESPOIR Registry, age 16.6 +/- 10.4 years, diameter 24.1 +/- 4.2 mm, follow-up 5.1 +/- 3.0 years. The combined DPH cohort, n = 235, comprising both Trial and Registry data showed significantly better freedom from explantation (DPH 96.7 +/- 2.1%, CH 84.4 +/- 3.2%, P = 0.029 and BJV 82.7 +/- 3.2%, P = 0.012) and less structural valve degeneration at 10 years when matched to CH, n = 235 and BJV, n = 235 (DPH 61.4 +/- 6.6%, CH 39.9 +/- 4.4%, n.s., BJV 47.5 +/- 4.5%, P = 0.029).CONCLUSIONS: Initial results of the prospective multicentre ESPOIR Trial showed DPH to be safe and efficient. Current DPH results including Registry data were superior to BJV and CH.Thoracic Surger

Physical Properties of Sessile Oak (Quercus Petraea L) Used by the Wood Industry in Kosovo

The paper shows some physical properties of sessile oak obtained in Kosovo regions. In the study are shown: wood shrinkage, specific gravity, shrinkage coefficient for 1% change of moisture content, ratio of shrinkage in tangential and radial direction etc. The amount of volumetric shrinkage of sessile oak is 15.95%, heartwood part has an average shrinkage 15.41% in The shrinkage of sapwood part is 17.56%. Specific gravity at: wet condition: (1.013gr/cm3); 12% (0.853gr/cm3) and 0% (0.826gr/cm3) of moisture content. Specific gravity of heartwood at: wet condition (1.05gr/cm3); 12% (0.88gr/cm3); 0% (0.85gr/cm3). The specific gravity of sapwood at: wet condition (0.91gr/cm3); 12% (0.77gr/cm3); 0% (0.748gr/cm3). The ratio of average shrinkage between tangential and radial cutting direction is 1.71%. This ratio was significantly higher in sapwood than heartwood. Coefficient of shrinkage (changing 1% of moisture content) in the radial direction is 0.00196, and 0.00323 in tangential direction. &nbsp

Supplementary Material for: Baló Concentric Sclerosis Mimicking Encephalitis with Seizure and Progressive Aphasia in a 26-Year-Old Woman: A Challenging Diagnostic Dilemma

Introduction: Baló's concentric sclerosis (BCS) is a rare subtype of multiple sclerosis (MS) characterized by inflammatory demyelination within the central nervous system (CNS). Case presentation: This case report presents a challenging diagnostic scenario involving a 26-year-old woman diagnosed with BCS. Despite treatment, her condition did not ameliorate, and magnetic resonance imaging (MRI) findings remained unchanged. A subsequent stereotactic biopsy revealed tumefactive Balo disease, highlighting the intricate diagnostic and therapeutic issues surrounding BCS. Conclusion: The juxtacortical location of the BCS lesion, as observed in our case, suggests an unfavourable prognosis due to treatment-resistant seizures

An In Vitro model of parallel-plate perfusion system to study bacterial adherence to graft tissues

Various valved conduits and stent-mounted valves are used for right ventricular outflow tract (RVOT) valve replacement in patients with congenital heart disease. When using prosthetic materials however, these grafts are susceptible to bacterial infections and various host responses. Identification of bacterial and host factors that play a vital role in endovascular adherence of microorganisms is of importance to better understand the pathophysiology of the onset of infections such as infective endocarditis (IE) and to develop preventive strategies. Therefore, the development of competent models to investigate bacterial adhesion under physiological shear conditions is necessary. Here, we describe the use of a newly designed in vitro perfusion chamber based on parallel plates that allows the study of bacterial adherence to different components of graft tissues such as exposed extracellular matrix, endothelial cells and inert areas. This method combined with colony-forming unit (CFU) counting is adequate to evaluate the propensity of graft materials towards bacterial adhesion under flow. Further on, the flow chamber system might be used to investigate the role of blood components in bacterial adhesion under shear conditions. We demonstrated that the source of tissue, their surface morphology and bacterial species specificity are not the major determining factors in bacterial adherence to graft tissues by using our in-house designed in vitro perfusion model.status: publishe